Patents by Inventor Philippe Guy Nicolas Baudu

Philippe Guy Nicolas Baudu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Feline calicivirus genes and vaccines in particular recombinant vaccines
    Patent number: 6914134
    Abstract: The invention relates to the sequence of the capsid gene and a corresponding cDNA sequence, of a dominant FCV strain called FCV 431. It also relates to the sequence of the capsid gene as well as the cDNA sequence of a complementary strain called G1. The cDNA sequences may be incorporated into expression vectors for the preparation of immunogenic preparations and of recombinant or subunit vaccines allowing vaccination against feline calicivirosis.
    Type: Grant
    Filed: July 30, 2002
    Date of Patent: July 5, 2005
    Assignee: Merial
    Inventors: Jean-Christophe Francis Audonnet, Philippe Guy Nicolas Baudu, Sylvie Claudine Brunet
  • Feline calicivirus genes and vaccines in particular recombinant vaccines
    Publication number: 20030109033
    Abstract: The invention relates to the sequence of the capsid gene and a corresponding cDNA sequence, of a dominant FCV strain called FCV 431. It also relates to the sequence of the capsid gene as well as the cDNA sequence of a complementary strain called G1. The cDNA sequences may be incorporated into expression vectors for the preparation of immunogenic preparations and of recombinant or subunit vaccines allowing vaccination against feline calicivirosis.
    Type: Application
    Filed: July 30, 2002
    Publication date: June 12, 2003
    Inventors: Jean-Christophe Francis Audonnet, Philippe Guy Nicolas Baudu, Sylvie Claudine Brunet
  • Feline calicivirus genes and vaccines in particular recombinant vaccines
    Patent number: 6541458
    Abstract: The invention relates to the sequence of the capsid gene and a corresponding cDNA sequence, of a dominant FCV strain called FCV 431. It also relates to the sequence of the capsid gene as well as the cDNA sequence of a complementary strain called G1. The cDNA sequences may be incorporated into expression vectors for the preparation of immunogenic preparations and of recombinant or subunit vaccines allowing vaccination against feline calicivirosis.
    Type: Grant
    Filed: July 14, 2000
    Date of Patent: April 1, 2003
    Assignee: Merial
    Inventors: Jean-Christophe Francis Audonnet, Philippe Guy Nicolas Baudu, Sylvie Claudine Brunet
  • Recombinant vaccine containing feline herpes virus type 1 particularly for treating feline infectious peritonitis
    Patent number: 6387376
    Abstract: The recombinant live vaccine comprises, as vector, a feline herpesvirus comprising and expressing at least one nucleotide sequence encoding a polypeptide, this sequence being inserted into the ORF5 and/or ORF2 sites. Polyvalent vaccine formula and feline herpesvirus DNA fragments.
    Type: Grant
    Filed: March 21, 2000
    Date of Patent: May 14, 2002
    Assignee: Merial
    Inventors: Jean-Christophe Francis Audonnet, Philippe Guy Nicolas Baudu, Michel Albert Emile Riviere
  • Recombinant composition containing feline herpes virus type 1, particularly for treating feline infectious peritonitis
    Patent number: 6074649
    Abstract: The recombinant live vaccine comprises, as vector, a feline herpesvirus comprising and expressing at least one nucleotide sequence encoding a polypeptide, this sequence being inserted into the ORF5 and/or ORF2 sites. Polyvalent vaccine formula and feline herpesvirus DNA fragments.
    Type: Grant
    Filed: May 15, 1998
    Date of Patent: June 13, 2000
    Assignee: Merial
    Inventors: Jean-Christophe Francis Audonnet, Philippe Guy Nicolas Baudu, Michel Albert Emile Riviere